Nephrostomy Devices Global Market Report 2024

Nephrostomy devices are medical tools utilized to establish and maintain an artificial passage between the kidney and the skin's surface, facilitating urine drainage. These devices play a crucial role in the management of conditions such as kidney stones, tumors, or strictures that obstruct urinary flow. They offer both temporary and long-term relief of symptoms while preserving kidney function.

The primary types of nephrostomy devices include guidewires, drainage tubes, nephrostomy catheters, sheath dilators, and others. Guidewires are slender, flexible wires that assist in guiding catheters or other medical instruments into position during nephrostomy procedures. They are employed in a range of applications including kidney diseases, urological cancers, benign prostatic hyperplasia (BPH), and various other medical procedures conducted by hospitals, clinics, ambulatory surgical centers (ASCs), and other end-users.

The nephrostomy devices market research report is one of a series of new reports that provides nephrostomy devices market statistics, including the nephrostomy devices industry global market size, regional shares, competitors with nephrostomy devices market share, detailed nephrostomy devices market segments, market trends, and opportunities, and any further data you may need to thrive in the nephrostomy devices industry. These nephrostomy devices market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The nephrostomy devices market size has grown strongly in recent years. It will grow from $1.11 billion in 2023 to $1.2 billion in 2024 at a compound annual growth rate (CAGR) of 8.4%. The growth observed in the historic period can be attributed to several factors including the rising prevalence of kidney stone disease, an aging population leading to increased healthcare needs, expanded reimbursement policies, wider application in urological procedures, heightened awareness among the population, increased incidence of kidney-related diseases, and improved healthcare infrastructure.

The nephrostomy devices market size is expected to see strong growth in the next few years. It will grow to $1.68 billion in 2028 at a compound annual growth rate (CAGR) of 8.8%. During the forecast period, growth is expected to be driven by several factors including the increasing prevalence of kidney-related diseases, a rising geriatric population, expanding healthcare infrastructure in emerging markets, growing awareness and diagnosis of urological disorders, increased investment in research and development, and heightened awareness about nephrostomy procedures. Key trends anticipated in this period include advancements in minimally invasive surgical techniques, technological innovations in medical devices, enhancements in medical imaging technologies, innovations in nephrostomy device design, and improvements in catheter technology.

The increasing incidence of kidney transplants is poised to drive the growth of the nephrostomy device market in the future. Kidney transplants involve surgically placing a healthy kidney from a donor into a patient with kidney failure. The rise in kidney transplants is attributed to the growing prevalence of chronic kidney disease and kidney failure, alongside advancements in medical technology and transplant procedures. Nephrostomy devices play a critical role in kidney transplants by providing temporary drainage directly from the kidneys, especially in cases involving urinary tract blockages. This helps maintain kidney function post-transplant, reducing the risk of infection or damage to the transplanted kidney during the crucial recovery phase. For instance, in 2022, the Health Resources and Services Administration reported a significant increase in adult candidates added to the kidney waiting list and a slight rise in total candidates listed for transplant, highlighting the demand driving the nephrostomy device market.

Key companies in the nephrostomy devices market are innovating with products such as pressure-injectable catheters to enhance procedural efficiency and patient outcomes. Pressure injection in catheters involves using controlled pressure to deliver fluids or medications through a catheter inserted into the body, specifically into the renal system for nephrostomy procedures. For example, Teleflex Incorporated launched the Arrow Pressure Injectable Midline in June 2022. This device features distinctive yellow hubs and labels for easy identification and prevents infusion errors. Its design ensures consistent French sizes, reducing the risk of venous stasis, while streamlined tray configuration and an ergonomic trimmer enable precise placement during procedures. Safety features allow rapid pressure injections up to 5 mL/second through either lumen, speeding up diagnosis and treatment processes.

In October 2023, Laborie Medical Technologies Corp acquired Urotronic Inc, a move aimed at integrating innovative technologies that enhance interventional urology procedures into their portfolio. Urotronic Inc, a US-based medical device company specializing in nephrostomy devices, will contribute its expertise to Laborie's efforts in preserving and restoring human dignity through advanced medical technologies.

Major companies operating in the nephrostomy devices market are Becton, Dickinson and Company, Stryker Healthcare, Boston Scientific Corporation, Olympus Corporation, Terumo Corporation, Coloplast Corp., B. Braun Medical Inc., Cook Medical, Teleflex Incorporated, Merit Medical Systems, AngioDynamics, Argon Medical Devices, Well Lead Medical Co. Ltd., Amecath, Medi-Globe GmbH, Envaste Limited, Troge Medical GmbH, Rocamed, Suru International Pvt.Ltd., UroMed, Electramed Ltd., Urovision-Urotech, Blueneem Medical Devices Pvt Ltd., Manfred Sauer UK, Surgimedik Healthcare India Pvt Ltd.

North America was the largest region in the nephrostomy devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nephrostomy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the nephrostomy devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The nephrostomy devices market consists of sales of nephrostomy tubes, catheters, guidewires, dilators, sheaths, and drainage bags. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.